HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016.

HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016

Figure 1: Newly diagnosed HIV notifications in Australia, 1984-2015, by sex
Source: State and Territory Health Authorities

Figure 2: Newly diagnosed HIV notifications in Australia, 1984-2015, by age group

Figure 3: Newly diagnosed HIV notifications, 2006 – 2015, by exposure category

Figure 4: Newly diagnosed HIV notification rate per 100 000 population, 2006 – 2015, by sex

Figure 5: Newly diagnosed HIV notification rate per 100 000 population, 2006 – 2015, by age group

Figure 6: Newly diagnosed HIV notification rate per population, 2006 – 2015, by age group, males Source: State and Territory Health Authorities

Figure 7: Newly diagnosed HIV notification rate per population, 2006 – 2015, by age group, females Source: State and Territory Health Authorities

Figure 8: Newly diagnosed HIV notification rate per population, 2006 – 2015, by State/Territory (1/2) Source: State and Territory Health Authorities

Figure 8: Newly diagnosed HIV notification rate per population, 2006 – 2015, by State/Territory (2/2) Source: State and Territory Health Authorities

Figure 9: Annual new HIV diagnoses as proportion of the estimated number of people diagnosed and living with HIV, 2006 – 2015 Source: State and Territory Health Authorities

Figure 10: Proportion of HIV diagnoses by region of birth (non‑Australian‑born men), in men reporting male‑to‑male sex as risk exposure, 2006 – 2015 Source: State and Territory Health Authorities

Figure 11: Number of new HIV diagnoses in men (reporting an exposure risk other than male‑to‑male sex), 2006 – 2015, by risk exposure category Source: State and Territory Health Authorities

Figure 12: Number of new HIV diagnoses in women, 2006 – 2015, by risk exposure category

Figure 13: Newly diagnosed HIV notification rate per population, 2006 – 2015, by country/region of birth Source: State and Territory Health Authorities

Figure 14: Newly diagnosed HIV notification rate per Australian‑born population, 2006 – 2015, by Aboriginal and Torres Strait Islander status Source: State and Territory Health Authorities

Figure 15: Newly diagnosed HIV and HIV exposure category, 2011 – 2015, by Aboriginal and Torres Strait Islander status Source: State and Territory Health Authorities

Figure 16: Number of Australian‑born children perinatally exposed to HIV and HIV positive, 1984 – 2015, by year of birth Source: Australian Paediatric Surveillance Unit

Figure 17: Proportion of Australian‑born perinatally exposed infants who were HIV positive, 2006 – 2015, by year of birth Source: Australian Paediatric Surveillance Unit

Figure 18: Newly diagnosed HIV in Australia, 2006 – 2015, by newly acquired1 HIV status and year

Figure 19: Exposure category of HIV diagnoses classified as newly acquired or unspecified1 in Australia, 2006 – 2015 Source: State and Territory Health Authorities

Figure 20: Newly acquired HIV notification rate per population, 2006 – 2015, by State/Territory (1/2) Source: State and Territory Health Authorities

Figure 20: Newly acquired HIV notification rate per population, 2006 – 2015, by State/Territory (2/2) Source: State and Territory Health Authorities

Figure 21: The proportion of late diagnoses in men who reported sex with men as an exposure risk, 2011 – 2015, by sub‑category (n=3 260) Source: State and Territory Health Authorities

Figure 22: The proportion of late diagnoses in people who reported heterosexual sex as an exposure risk, 2011 – 2015, by sub‑category (n=490), males Source: State and Territory Health Authorities

Figure 23: The proportion of late diagnoses in people who reported heterosexual sex as an exposure risk, 2011 – 2015, by sub‑category (n=397), females Source: State and Territory Health Authorities

Figure 24: Proportion of late1 HIV diagnoses, 2006 – 2015, by select exposure category
1 Late HIV diagnosis was defined as newly diagnosed HIV with a CD4+ cell count of less than 350 cells/μl Source: State and Territory Health Authorities

Figure 25: Estimated number of people living with HIV by reported exposure category, Australia, 2015

Figure 26: Estimated HIV prevalence in selected countries, 2015
Source: UNAIDS, HIV in the United Kingdom: 2014 Report

Figure 27: Self‑reported HIV prevalence among gay men participating in the Gay Community Periodic Survey, 2006 – 2015 Source: Gay Community Periodic Survey

Figure 28: HIV prevalence among people seen at needle and syringe programs, 2006 – 2015, by sexual identity Source: Australian Needle and Syringe Program Survey

Figure 29: The HIV diagnosis and care cascade, 2013 – 2015
Note: Due to updated modelling methods, estimates may be different to figures presented in previous years of reporting Source: see Methodological Notes of the report for details of mathematical modelling used to generate estimates

Figure 30: Proportion of non‑HIV‑positive men tested for HIV in the 12 months prior to completing the survey, 2006 – 2015 Source: Gay Community Periodic Survey

Figure 31: Proportion of sexual health and high case load clinic1 attendees tested for HIV in a year, 2011 – 2015 1 Primary health care general practice clinics with a high case load of gay and bisexual men Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs),

Figure 32: Average number of HIV tests per year in gay and bisexual men attending sexual health clinics participating in ACCESS, 2011 – 2015 Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs),

Figure 33: Proportion of people who inject drugs who attended needle and syringe programs and reported an HIV test in the past twelve months, 2006 – 2015, by sex Source: Australian Needle and Syringe Program Survey

Figure 34: Proportion of HIV‑positive men on antiretroviral treatment in two data sources, 2006 – 2015 Source: Gay Community Periodic Survey; The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 35: Viral load suppression1 from patients in the Australian HIV Observational Database, sexual health clinics and high case load general practice clinics 2006 – 2015 1 Undetectable viral load equals 200 copies/ml or less Source: Australian HIV Observational Database; The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 36: Gay men with casual partners who reported any condomless anal intercourse in the six months prior to the survey, 2006 – 2015 Source: Gay Community Periodic Survey

Figure 37: HIV incidence rate per 100 person years in men who have sex with men and female sex workers attending sexual health clinics, 2011 – 2015 Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Hepatitis C

Figure 38: Hepatitis C notification rate per 100 000 population, 2006 – 2015, by sex
Source: Australian National Notifiable Diseases Surveillance System

Figure 39: Hepatitis C notification rate per 100 000 population, 2006 – 2015, by year and age group

Figure 40: Hepatitis C notification rate per 100 000 population, 2006 – 2015, by age group, males

Figure 41: Hepatitis C notification rate per 100 000 population, 2006 – 2015, by age group, females

Figure 42: Hepatitis C notification rate per population, 2006 – 2015, by State/Territory (1/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 42: Hepatitis C notification rate per population, 2006 – 2015, by State/Territory (2/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 43: Hepatitis C notification rate per 100 000 population, 2006 – 2015 by region of residence

Figure 44: Hepatitis C notification rate per , 2011 – 2015, by Aboriginal and Torres Strait Islander status Includes jurisdictions (Northern Territory, Western Australia, South Australia and Tasmania) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year Source: Australian National Notifiable Diseases Surveillance System

Figure 45: Hepatitis C notification rate per , 2011 – 2015, by State/Territory and Aboriginal and Torres Strait Islander status Includes jurisdictions (Northern Territory, Western Australia, South Australia and Tasmania) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year Source: Australian National Notifiable Diseases Surveillance System

Figure 46: Newly acquired hepatitis C notification rate per population, 2006 – 2015, by age group Source: Australian National Notifiable Diseases Surveillance System

Figure 47: Hepatitis C prevalence1 among people seen at needle and syringe programs, 2006 – 2015, by sex 1 Among respondents tested Source: Australian Needle and Syringe Program Survey

Figure 48: Hepatitis C prevalence among prison entrants, 2004, 2007, 2010, 2013
Source: National Prison Entrants’ Bloodborne Virus Survey 2004, 2007, 2010, and 2013

Figure 49: Estimated number of people at different stages of hepatitis C related liver morbidity, and estimated number of deaths, 2006 – 2015 Source: see Methodological Notes of report for detail

Figure 50: The hepatitis C diagnosis and care cascade, 2013 – 2015
Note: Due to updated modelling methods, estimates may be different to figures presented in previous years of reporting Source: see Methodological Notes of report for detail

Figure 51: Proportion of people who inject drugs seen at needle and syringe programs who reported a hepatitis C antibody test in the past 12 months, 2006 – 2015, by sex Source: Australian Needle and Syringe Program Survey

Figure 52: Proportion of sexual health attendees tested for hepatitis C in a year, by select population and year, 2011 – 2015 Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 53: The number of people receiving hepatitis C treatment, 1997 – 2015
Source: PharmDash, Pharmaceutical companies, personal communication

Figure 54: Proportion of hepatitis C antibody positive people seen at needle and syringe programs with a history of hepatitis C treatment, 2008 – 2015 Source: Australian Needle and Syringe Program Survey

Figure 55: Proportion of people seen at Needle and Syringe Programs reporting receptive syringe sharing in the last month, 2006 – 2015, by sex Source: Australian Needle and Syringe Program Survey

Figure 56: Estimated annual incidence of hepatitis C virus infection among people who inject drugs, seen at needle and syringe programs, 2006 – 2014 Source: Australian Needle and Syringe Program Survey

Figure 57: Estimated annual incidence of hepatitis C virus infection among people who inject drugs seen Kirketon Road Centre, Sydney NSW, 2006 – 2015 Source: Kirketon Road Centre, Sydney NSW

Hepatitis B

Figure 58: Hepatitis B notification rate per 100 000 population, 2006 – 2015, by sex

Figure 59: Hepatitis B notification rate per population, 2006 – 2015, by year and selected age group Source: Australian National Notifiable Diseases Surveillance System

Figure 60: Hepatitis B notification rate per population, 2006 – 2015, by year and selected age group Source: Australian National Notifiable Diseases Surveillance System

Figure 61: Hepatitis B notification rate per 100 000 population, 2006 – 2015, by age group, males

Figure 62: Hepatitis B notification rate per 100 000 population, 2006 – 2015, by age group, females

Figure 63: Hepatitis B notification rate per population, 2006 – 2015, by State/Territory (1/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 63: Hepatitis B notification rate per population, 2006 – 2015, by State/Territory (2/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 64: Hepatitis B notification rate per 100 000 population, 2006 – 2015, by region of residence

Figure 65: Hepatitis B notification rate per population, 2011 – 2015, by Aboriginal and Torres Strait Islander status Includes jurisdictions (Australian Capital Territory, Northern Territory, South Australia, Tasmania, Western Australia) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 66: Hepatitis B notification rate per , 2011 – 2015, by State/Territory and Aboriginal and Torres Strait Islander status Includes jurisdictions (Australian Capital Territory, Northern Territory, South Australia, Tasmania, Western Australia) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 67: Newly acquired hepatitis B notification rate per 100 000 population, 2006 – 2015, by sex

Figure 68: Newly acquired hepatitis B notification rate per population, 2006 – 2015, by year and selected age group Source: Australian National Notifiable Diseases Surveillance System

Figure 69: Newly acquired hepatitis B notification rate per population, 2006 – 2015, by year and selected age group Source: Australian National Notifiable Diseases Surveillance System

Figure 70: Estimated prevalence of chronic hepatitis B infection in Australia, 2015, by country of birth Source: WHO Collaborating Centre for Viral Hepatitis, Victorian Infectious Diseases Reference Laboratory, Doherty Institute

Figure 71: Chronic hepatitis B prevalence among prison entrants, 2004, 2007, 2010 and 2013
Source: National Prison Entrants’ Bloodborne Virus Survey 2004, 2007, 2010, and 2013

Figure 72: The hepatitis B diagnosis and care cascade, 2013 – 2015
Note: Due to updated modelling methods, estimates may be different to figures presented in previous years of reporting Source: WHO Collaborating Centre for Viral Hepatitis, Victorian Infectious Diseases Reference Laboratory, Doherty Institute

Figure 73: Proportion of people attending sexual health clinics with immunity to hepatitis B1, based on vaccination documentation and serology, 2015, by age group2 1 Vaccinated or immunity from past exposure 2 Data from 41 sexual health clinics across Australia Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 74: Estimated number of people dispensed treatment for hepatitis B infection, by treatment type, 2013 – 2015 Note: Excludes tenofovir dispensations for HIV co‑infected patients Source: PharmDash

Figure 75: Hepatitis B vaccination coverage estimates at 12 and 24 months, 2011 – 2015, by Aboriginal and Torres Strait Islander status Source: National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

Sexually transmissible infections

Figure 76: Chlamydia notification rate per 100 000, 2006 – 2015, by sex
Note: Excludes Victoria in 2015 as data were unavailable at the time of reporting, but will be available in the future Source: Australian National Notifiable Diseases Surveillance System

Figure 77: Chlamydia notification rate per 100 000, 2006 – 2015, by age group

Figure 78: Chlamydia notification rate per 100 000, 2006 – 2015, by age group, males

Figure 79: Chlamydia notification rate per 100 000, 2006 – 2015, by age group, females

Figure 80: Chlamydia notification rate per population, 2006 – 2015, by year and State/Territory (1/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 80: Chlamydia notification rate per population, 2006 – 2015, by year and State/Territory (2/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 81: Chlamydia notification rate per 100 000, 2006 – 2015, by region of residence

Figure 82: Chlamydia notification rate per 100 000, 2006 – 2015, by region of residence, males

Figure 83: Chlamydia notification rate per 100 000, 2006 – 2015, by region of residence, females

Figure 84: Chlamydia notification rate per , 2011 – 2015, by Aboriginal and Torres Strait Islander status Includes jurisdictions (Northern Territory, Queensland, South Australia, and Western Australia) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 85: Chlamydia notification rate per , 2011 – 2015, by Aboriginal and Torres Strait Islander status and State/Territory Includes jurisdictions (Northern Territory, Queensland, South Australia, and Western Australia) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 86: Ratio of chlamydia notifications to Medicare‑rebated chlamydia tests, 2008 – 2015, by sex
Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 87: Ratio of chlamydia notifications to Medicare‑rebated chlamydia tests, 2008 – 2015, by age group, males Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 88: Ratio of chlamydia notifications to Medicare‑rebated chlamydia tests, 2008 – 2015, by age group, females Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 89: Gonorrhoea notification rate per 100 000 population, 2006 – 2015, by sex

Figure 90: Gonorrhoea notification rate per 100 000 population, 2006 – 2015, by age group

Figure 91: Gonorrhoea notification rate per 100 000 population, 2006 – 2015, by age group, males

Figure 92: Gonorrhoea notification rate per 100 000 population, 2006 – 2015, by age group, females

Figure 93: Gonorrhoea notification rate per population, 2006 – 2015, by State/Territory (1/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 93: Gonorrhoea notification rate per population, 2006 – 2015, by State/Territory (2/2) Note: Northern Territory is on the right hand axis Source: Australian National Notifiable Diseases Surveillance System

Figure 94: Gonorrhoea notification rate per 100 000, 2006 – 2015 by region of residence

Figure 95: Gonorrhoea notification rate per population, 2006 – 2015, by region of residence, males Source: Australian National Notifiable Diseases Surveillance System

Figure 96: Gonorrhoea notification rate per population, 2006 – 2015, by region of residence, females Source: Australian National Notifiable Diseases Surveillance System

Figure 97: Gonorrhoea notification rate per population, 2011 – 2015, by Aboriginal and Torres Strait Islander status Includes jurisdictions (Australian Capital Territory, Northern Territory, Queensland, South Australia, Victoria, Western Australia and Tasmania) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 98: Gonorrhoea notification rate per population, 2011 – 2015, by State/Territory and Aboriginal and Torres Strait Islander status Includes jurisdictions (Australian Capital Territory, Northern Territory, Queensland, South Australia, Victoria, Western Australia and Tasmania) in which Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 99: Ratio of gonorrhoea notifications to Medicare‑rebated gonorrhoea tests, 2012 – 2015, by sex Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 100: Ratio of gonorrhoea notifications to Medicare‑rebated gonorrhoea tests, 2012 – 2015, by age group, males Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 101: Ratio of gonorrhoea notifications to Medicare‑rebated gonorrhoea tests, 2012 – 2015, by age group, females Source: Australian National Notifiable Diseases Surveillance System; Medicare, Department of Human Services

Figure 102: Proportion of gonococcal isolates referred to the Australian Gonococcal Surveillance Program with decreased susceptibility to ceftriaxone (MIC 0.06 – 0.125mg/L), Australia, 2010 – 2015, by State/Territory Source: Australian Gonococcal Surveillance Program

Figure 103: Infectious syphilis notification rate per 100 000 population, 2006-2015, by sex

Figure 104: Infectious syphilis notification rate per 100 000 population, 2006-2015, by age group

Figure 105: Infectious syphilis notification rate per population, , by age group, males Source: Australian National Notifiable Diseases Surveillance System

Figure 106: Infectious syphilis notification rate per population, , by age group, females Source: Australian National Notifiable Diseases Surveillance System

Figure 107: Infectious syphilis notification rate per population, , by State/Territory (1/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 107: Infectious syphilis notification rate per population, , by State/Territory (2/2) Source: Australian National Notifiable Diseases Surveillance System

Figure 108: Infectious syphilis notification rate per population, , by region of residence Source: Australian National Notifiable Diseases Surveillance System

Figure 109: Infectious syphilis notification rate per population, , by Aboriginal and Torres Strait Islander status Includes jurisdictions all jurisdictions, as Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 110: Infectious syphilis notification rate per population, , by State/Territory and Aboriginal and Torres Strait Islander status Includes jurisdictions all jurisdictions, as Aboriginal and Torres Strait Islander status was reported for ≥50% of diagnoses for each year. Source: Australian National Notifiable Diseases Surveillance System

Figure 111: Annual number of notifications of congenital syphilis, 2006-2015

Figure 112: Annual number of notifications of donovanosis, 2006-2015

Figure 113: The 2015 chlamydia diagnosis and care cascade in 15-29 year olds, by sex
Source: See Methodological notes of the full report for further details of mathematical modelling used to generate estimates

Figure 114: Number of Medicare-rebated chlamydia tests in Australia, 2008-2015, by sex
Source: Medicare, Department of Human Services

Figure 115: Proportion of 15-29 old GP attendees tested for chlamydia, 2008-2015, by sex
Source: Medicare, Department of Human Services

Figure 116: Average number of syphilis tests per year in gay and bisexual men, 2011 – 2015, by HIV status Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 117: Gay men who reported having at least four samples collected for STI testing (blood, urine, anal and throat swabs) in the 12 month prior to the survey: Gay Community Periodic Survey, 2006 – 2015 Source: Gay Community Periodic Survey

Figure 118: Repeat comprehensive STI screen (within 13 months) at sexual health clinics, by select population, 2011 – 2015 Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 119: Chlamydia re‑testing at sexual health clinics, 2011 – 2015
Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 120: Chlamydia incidence in HIV‑negative and positive gay and bisexual men attending sexual health clinics, 2010 – 2015, by anatomical site Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 121: Gonorrhoea incidence in HIV‑negative and positive gay and bisexual men attending sexual health clinics, 2010 – 2015, by anatomical site Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 122: Infectious syphilis incidence in HIV negative and positive gay and bisexual men attending sexual health clinics, Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 123: Incidence of sexually transmissible infections in female sex workers, 2011 – 2015
Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 124: Incidence of sexually transmissible infections in females not engaged in sex work, 2011 – 2015 Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 125: Three dose HPV vaccination coverage for all females turning 15 years of age, 2007 – 2015, by State/Territory (1/2) Source: National HPV Vaccination Program Register

Figure 125: Three dose HPV vaccination coverage for all females turning 15 years of age, 2007 – 2015, by State/Territory (2/2) Source: National HPV Vaccination Program Register

Figure 126: Three dose HPV vaccination coverage for all males 15 years of age, 2013 – 2015
Source: National HPV Vaccination Program Register

Figure 127: Proportion of Australian‑born women diagnosed with genital warts at first visit at sexual health clinics, 2004 – 2015, by select age group Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 128: Proportion of Australian‑born heterosexual men diagnosed with genital warts at first visit at sexual health clinics, 2004 – 2015, by select age group Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 129: Proportion of Australian‑born homosexual or bisexual men diagnosed with genital warts at first visit at sexual health clinics, 2004 – 2015, by year Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 130: Proportion of Aboriginal and Torres Strait Islander males diagnosed with genital warts at first visit at sexual health clinics, 2004 – 2015, by age group Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 131: Proportion of Aboriginal and Torres Strait Islander females diagnosed with genital warts at first visit at sexual health clinics, 2004 – 2015, by age group Source: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections (STIs) and Blood Borne Viruses (BBVs)

Figure 132: High‑grade abnormality detection rate, per women undergoing Pap screening, 2006 – 2014 Source: Australian Institute of Health and Welfare ‘Cervical Screening in Australia 2013 – 2014’)

New surveillance website

HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016.

Similar presentations

Presentation on theme: "HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016."— Presentation transcript:

Similar presentations

About project

Feedback

Log in

Auth with social network:

HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016.

Similar presentations

Presentation on theme: "HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016."— Presentation transcript:

Similar presentations

About project

Feedback